number
public
relat
acut
otiti
media
aom
otiti
media
effus
ome
increas
markedli
within
last
year
point
difficulti
give
gener
accept
guidelin
treatment
confus
partial
explain
absenc
uniform
definit
inhomogen
group
patient
includ
clinic
studi
aom
acut
inflamm
middl
ear
frequent
elicit
viral
infect
character
red
bulg
tympanum
infect
bacteria
identifi
least
case
cultur
middl
ear
purul
fluid
contain
mainli
polymorphonuclear
cell
ome
effus
middl
ear
without
symptom
acut
inflamm
pain
fever
frequent
amber
opaqu
aspect
tympanum
effus
contain
mainli
macrophag
retract
tympanum
light
reflex
still
present
may
render
diagnosi
difficult
cultur
bacteria
posit
case
wherea
virus
identifi
ome
may
precursor
event
initi
suppur
aom
continuum
aom
well
ome
direct
consequ
impair
middl
ear
ventil
tympanometri
fig
show
flat
curv
type
b
aom
ome
contrast
ome
associ
incomplet
obstruct
eustachian
tube
et
curv
c
peak
neg
pressur
zone
observ
moreov
lower
peak
height
greater
width
neg
pressur
zone
frequent
find
ome
overview
summar
main
new
find
aom
ome
accord
basic
wellknown
sometim
forgotten
data
fact
particular
emphasi
vulner
young
children
age
year
great
import
first
attack
aom
young
children
lie
subsequ
longlast
dysfunct
et
inde
main
function
et
ventil
protect
clearanc
middl
ear
fig
play
determin
role
recurr
aom
ventil
middl
ear
occur
deglutit
action
tensor
velum
palatinum
muscl
lead
air
equilibr
atmospher
pressur
obstruct
et
neg
pressur
develop
insid
middl
ear
result
effus
aspir
nasopharyng
secret
poor
ventil
lead
decreas
result
decreas
bactericid
power
polymorphonuclear
cell
impair
clearanc
result
prolifer
aerob
also
anaerob
bacteria
middl
ear
convers
reflux
otiti
occur
decreas
complianc
et
due
abnorm
flaccid
et
dysfunct
major
problem
young
child
small
calibr
et
well
horizont
direct
fig
respons
high
incid
aom
frequent
relaps
viral
infect
explain
poor
longterm
prognosi
evidenc
prospect
studi
compris
aom
patient
less
year
age
damoiseaux
et
al
least
patient
recurr
aom
persist
ome
observ
month
month
yet
patient
treat
amoxicillin
unfortun
author
mention
either
delay
treatment
dosag
antibiot
word
first
episod
aom
determin
evolut
recurr
associ
acut
inflamm
involv
also
et
children
infect
respiratori
syncyti
viru
rsv
first
year
life
prospect
studi
children
age
month
bronchiol
show
aom
entri
within
day
addit
develop
ome
patient
remain
free
aom
ome
observ
period
find
confirm
recent
studi
show
patient
persist
rsv
antigen
middl
ear
effus
relaps
despit
favour
outcom
first
aom
episod
associ
aom
sever
viral
infect
larg
document
preval
respiratori
virus
middl
ear
fluid
children
age
month
year
aom
rsv
frequent
viru
isol
follow
parainfluenza
influenza
enterovirus
adenovirus
find
confirm
other
rhinoviru
coronaviru
metapneumoviru
ad
abovement
list
even
measl
viru
recent
isol
middl
ear
fluid
two
patient
patient
aom
bacteria
found
cultur
middl
ear
fluid
frequent
speci
isol
haemophilu
influenza
streptococcu
pneumonia
nasopharyng
aspir
cultur
may
give
valuabl
inform
bacteria
involv
aom
presenc
conjunct
point
haemophilu
influenza
infect
heikkinen
et
al
found
streptococcu
pneumonia
patient
haemophilu
influenza
moraxella
catarrhali
demonstr
recurr
aom
associ
posit
bacteri
cultur
nasopharynx
even
end
antibiot
treatment
case
pathogen
streptococcu
pneumonia
howev
recurr
day
initi
aom
episod
mostli
due
new
infect
ie
true
relaps
recent
prospect
studi
purul
mening
associ
aom
found
half
patient
bulut
et
al
perform
bacteri
viral
test
children
aom
patient
age
month
year
receiv
antibiot
week
prior
studi
posit
bacteri
cultur
obtain
children
respiratori
virus
identifi
combin
viral
bacteri
infect
demonstr
sampl
persist
otiti
document
children
combin
viral
bacteri
infect
prospect
studi
children
viral
infect
contribut
et
dysfunct
mastoid
treat
antibiot
accord
bacteri
resist
temporarili
insert
tympanostomi
tube
improv
drainag
narrow
calibr
aditu
ad
antrum
fig
wait
see
approach
advoc
treatment
aom
children
mainli
increas
antimicrobi
resist
bacteria
caus
respiratori
infect
inde
metaanalysi
children
age
month
year
collect
random
trial
conclud
signific
modest
impact
antibiot
primari
control
aom
similar
result
emerg
subsequ
studi
publish
damoiseaux
et
al
random
doubleblind
prospect
trial
carri
gener
practition
children
age
month
year
show
mayb
need
antibiot
studi
howev
suffer
major
flaw
absenc
longterm
data
particular
recurr
rate
aom
ome
consid
end
point
moreov
former
studi
includ
patient
larg
age
rang
therefor
blunt
effect
critic
age
group
patient
age
year
inde
aom
patient
present
first
attack
first
year
life
within
year
age
visualis
tympanum
age
group
alway
easi
especi
cerumen
obstruct
narrow
extern
ear
channel
yet
alreadi
mention
bulg
red
tympan
membran
import
diagnost
sign
bacteri
aom
crucial
role
first
attack
aom
make
immedi
administr
antibiot
mandatori
patient
aom
red
bulg
tympanum
tabl
wait
see
approach
increas
inflamm
henc
et
dysfunct
choic
antibiot
must
take
account
penetr
middl
ear
type
bacteria
involv
penetr
blood
much
higher
cephalosporin
macrolid
lower
cotrimoxazol
penetr
amoxicillin
chang
addit
clavulan
amoxicillin
increas
incid
streptococcu
pneumonia
intermediari
resist
dosag
amoxicillin
doubl
ie
mgkg
per
day
given
three
administr
recommend
center
diseas
control
prevent
haemophilu
influenza
like
becom
posit
previou
antibiot
administr
therefor
addit
dose
mgkg
per
amoxicillin
make
sens
moraxella
catarrhali
strain
nowaday
also
posit
durat
antibiot
treatment
matter
discuss
children
less
year
age
cours
reason
pneumootoscopi
tympanometri
help
appreci
permeabl
et
care
followup
necessari
nasopharyng
aspir
cultur
may
give
valuabl
result
highli
recommend
children
remain
day
care
centr
histori
previou
aom
episod
children
year
age
previous
watch
guidelin
maintain
flexibl
recommend
approach
ome
must
take
account
natur
histori
spontan
heal
main
complic
temporari
hear
impair
absenc
spontan
heal
week
month
children
year
age
indic
antibiot
cours
accord
result
nasopharyng
aspir
cultur
experi
approach
sever
advantag
first
effect
even
temporarili
hear
defect
frequent
success
second
decreas
recurr
aom
improv
et
function
third
allow
postpon
avoid
tympanostomi
tube
insert
improv
hear
point
improv
permeabl
et
delay
week
month
treatment
ome
tabl
base
durat
ome
inde
prospect
studi
renko
et
al
children
aom
year
age
treat
amoxicillin
cefuroxim
axetil
day
mean
durat
ome
day
rang
day
still
ome
day
longterm
prospect
studi
healthi
infant
treat
accord
specifi
guidelin
paradis
et
al
observ
bilater
ome
children
receiv
tympanostomi
tube
age
indic
insert
tube
equivoc
larg
prospect
studi
infant
young
children
paradis
group
shown
absenc
neglig
effect
tympanostomi
development
outcom
year
hand
insert
tympanostomi
tube
first
year
life
associ
complic
least
patient
tympanostomi
sourc
bacteri
infect
tympanosclerosi
extens
review
kubba
et
al
rosenfeld
et
al
rover
et
al
recent
cochran
databas
lou
et
al
conclud
small
benefit
convent
ventil
tube
main
reason
poor
result
tympanostomi
tube
absenc
effect
et
dysfunct
never
demonstr
tympanostomi
tube
improv
function
et
recommend
american
academi
pediatr
insert
tube
condit
persist
hear
loss
db
particularli
posterosuperior
retract
pocket
ossicular
eros
adhes
atelectasi
increas
structur
damag
effus
durat
watch
wait
month
winter
period
seem
advis
children
mild
hear
deficit
adenoidectomi
consid
children
year
age
nasopharyng
obstruct
recurr
adenoid
effect
pneumococc
vaccin
recurr
aom
studi
extens
random
control
trial
brouwer
et
al
children
age
year
recurr
aom
effect
children
treat
heptaval
pneumococc
vaccin
compar
children
receiv
hepat
b
vaccin
studi
conclud
benefici
effect
similar
conclus
drawn
studi
van
kempen
et
al
children
age
year
cochran
databas
straeteman
et
al
shift
caus
pathogen
observ
streptococcu
pneumonia
haemophilu
influenza
strain
pneumococci
one
includ
vaccin
slight
reduct
incid
aom
observ
usa
high
incid
ome
observ
neonat
intens
care
unit
due
nasal
place
tube
ventilatori
assist
suggest
immun
immatur
impair
neuromotor
function
predispos
complic
vaccin
heptaval
pneumococc
vaccin
advoc
prematur
babi
neonat
studi
provid
inform
actual
aom
preval
control
group
receiv
hepat
b
vaccin
rememb
meconium
aspir
entri
middl
ear
associ
increas
risk
aom
therefor
earli
nasopharyng
suction
mandatori
